Clinical Trial Update: A Phase 2a, Efficacy and Safety Study of Duvelisib in Mild Asthmatic Subjects [Phase 2]

View source ↗

Summary

A Phase 2a study evaluating the efficacy and safety of duvelisib in mild asthmatic subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Duvelisib (duvelisib)

Snippet

Sponsor: SecuraBio | Conditions: Asthma | Phase 2 | Status: COMPLETED